[Small-cell lung carcinoma with long-term survival: a case report and review of the literature]

Nan Fang Yi Ke Da Xue Xue Bao. 2023 Dec 20;43(12):2152-2157. doi: 10.12122/j.issn.1673-4254.2023.12.22.
[Article in Chinese]

Abstract

We report a rare case of small-cell lung carcinoma with long-term survival treated in the Department of Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine. The pathological-clinical features and diagnosis-treatment progress were analyzed, and the comprehensive treatment strategies, tumor heterogeneity and prognosis of this tumor type were discussed by comparing with other previous studies. The 62-year-old patient was diagnosed with small-cell lung carcinoma and received surgery, radiotherapy and multi-line treatment, and had survived for 13 years after the surgery. The heterogeneity of small cell lung carcinoma should be carefully evaluated to improve the prognosis of the patients.

目的: 旨在提高对小细胞肺癌异质性的认知,达到个体化诊治的目的,改善小细胞肺癌患者的生存预后。

方法: 本研究报道由上海交通大学医学院附属仁济医院肿瘤科收治的1例小细胞肺癌长生存病例,分析其临床病理特点、诊疗过程,并结合文献复习,讨论小细胞肺癌的综合治疗策略、异质性及预后。

结果: 经过综合治疗,本例患者生存时间超13年。

结论: 小细胞肺癌长期生存病例罕见,应提高对小细胞肺癌异质性的认知,改善小细胞肺癌患者的生存预后。

Keywords: long-term survival; small-cell lung carcinoma; tumor heterogeneity.

Publication types

  • Review
  • Case Reports
  • English Abstract

MeSH terms

  • China
  • Humans
  • Lung
  • Lung Neoplasms*
  • Middle Aged
  • Small Cell Lung Carcinoma*

Grants and funding

国家自然科学基金(82073195,82271883);上海市宝山区科学技术委员会科技创新专项(20-E-32);申康三年行动计划医企融合创新成果转化专项(SHDC2022CRD043);上海交通大学医学院附属仁济医院宝山分院临床科研创新培育基金项目(2019-rbcxjj-001);上海交通大学医学院“双百人”计划